Researchers examined the effect of biologic therapy use on incident psoriatic arthritis among patients with psoriasis.

Lifestyle risk factors, particularly obesity and smoking, contribute to elevated disease activity in psoriatic arthritis.

Weight loss after a psoriasis diagnosis lowers the risk of developing psoriatic arthritis and keeping weight off matters, but ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...

From recognizing the early signs to building healthier everyday habits, explore expert-backed guidance for managing psoriasis ...

USA: A large analysis of hundreds of thousands of patient records has found that newer antidiabetic drug classes are ...

For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Fla., received a coupon card to help him pay for a psoriatic ...

Takeda has unveiled more data from its phase 3 trials of zasocitinib, demonstrating that the once-daily pill was able to ...

Johnson & Johnson JNJ, a healthcare behemoth with a market cap exceeding $600 billion and a portfolio spanning ...

Jul 16, 2026-- Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a nex ...

Psoriasis is driven by a complex interplay between innate and adaptive immunity, characterised by dysregulated keratinocyte proliferation, barrier disruption and a self‐sustaining inflammatory milieu.

The key secondary endpoints found the PsO pill to be beneficial in high-impact areas, including the scalp, palms, and soles.